Dogwood Therapeutics, Stock Current Asset
| DWTX Stock | 2.56 0.04 1.54% |
Dogwood Therapeutics, fundamentals help investors to digest information that contributes to Dogwood Therapeutics,'s financial success or failures. It also enables traders to predict the movement of Dogwood Stock. The fundamental analysis module provides a way to measure Dogwood Therapeutics,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dogwood Therapeutics, stock.
Other Current Assets is likely to drop to 3,310 in 2024. Total Current Assets is likely to drop to about 4 M in 2024. Dogwood | Current Asset |
Dogwood Therapeutics, Company Current Asset Analysis
Dogwood Therapeutics,'s Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Dogwood Current Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Dogwood Therapeutics, is extremely important. It helps to project a fair market value of Dogwood Stock properly, considering its historical fundamentals such as Current Asset. Since Dogwood Therapeutics,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dogwood Therapeutics,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dogwood Therapeutics,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Dogwood Current Asset Historical Pattern
Today, most investors in Dogwood Therapeutics, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Dogwood Therapeutics,'s growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Dogwood Therapeutics, current asset as a starting point in their analysis.
Dogwood Therapeutics, Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Dogwood Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Dogwood Therapeutics, has a Current Asset of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Dogwood Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dogwood Therapeutics,'s direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dogwood Therapeutics, could also be used in its relative valuation, which is a method of valuing Dogwood Therapeutics, by comparing valuation metrics of similar companies.Dogwood Therapeutics, is currently under evaluation in current asset category among its peers.
Dogwood Fundamentals
| Net Income | (5.3 M) | ||||
| Total Debt | 358.55 K | ||||
| Total Asset | 4.17 M | ||||
| Retained Earnings | (61.47 M) | ||||
| Working Capital | 3.81 M | ||||
| Net Asset | 4.17 M |
About Dogwood Therapeutics, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dogwood Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dogwood Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dogwood Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Dogwood Stock Analysis
When running Dogwood Therapeutics,'s price analysis, check to measure Dogwood Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dogwood Therapeutics, is operating at the current time. Most of Dogwood Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Dogwood Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dogwood Therapeutics,'s price. Additionally, you may evaluate how the addition of Dogwood Therapeutics, to your portfolios can decrease your overall portfolio volatility.